NCT00546923View on ClinicalTrials.gov

Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

210

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

June 30, 2006

Conditions

Anxiety DisordersDepression

Interventions

DRUG

Venlafaxine XR

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00546923 - Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients | Biotech Hunter | Biotech Hunter